medigraphic.com
SPANISH

Revista Médica de Costa Rica y Centroamérica

Colegio de Medicos y Cirujanos República de Costa Rica
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2014, Number 610

<< Back Next >>

Rev Med Cos Cen 2014; 71 (610)

Sindrome de Stevens-Johnson y necrólisis epidérmica tóxica

Barrantes MR, Espinoza MK
Full text How to cite this article

Language: Spanish
References: 10
Page: 305-308
PDF size: 166.56 Kb.


Key words:

No keywords

ABSTRACT

Stevens-Johnson syndrome and toxic epidermal necrolysis is a disorder of immune complexmediated hypersensitivity that is a severe expression of erythema multiforme, typically involving the skin, oral cavity, eyes and genitals. It is caused by many drugs, infections and malignant tumors. Its pathogenesis is still partially unknown, and no specific treatment has been shown to be clearly beneficial, therefore, the best treatment is early diagnosis, withdrawal of the suspect drug and support therapy.


REFERENCES

  1. Jean-Aan M, Tay Y, Stevens-Johnson syndrome and toxic epidermal necrolysis in Asian children, Journal of the American Academy of Dermatology, Volume 62, Issue 1, January 2010, 54-60.

  2. Laguna C, Martín B, Torrijos A, García-Melgares M, Febrer I, Síndrome de Stevens-Johnson y necrólisis epidérmica tóxica: experiencia clínica y revisión de la literatura especializada, Actas Dermo-Sifiliográficas, Volume 97, Issue 3, April 2006, 177-185.

  3. Martínez-Pérez J, Caldevilla- Bernardo D, Perales-Pardo R, Pérez- Gómez F. Síndrome de Stevens- Johnson, a propósito de un caso de fiebre y erupción cutánea. Semergen. 2012; 38:549.

  4. Roujeau J Epidermal necrolysis (Steven-Johnson syndrome and toxic epidermal necrolysis): Historical considerations. DERMATOLOGICA SINICA 31 (2013) 169e174.

  5. Sasankoti Mohan R, Verma S, Gill N, Tyagi K. Stevens–Johnson syndrome: An illustrative report of a case.Indian Journal of Dentistry - June 2013, Vol. 4, Issue 2, 105-109.

  6. Su S, Chung W, Update on pathobiology in Stevens-Johnson syndrome and toxic epidermal necrolysis. Dermatologica Sinica - December 2013 Vol. 31, Issue 4, 175-180.

  7. Suenaga H, Saijo H, Hoshi K, Mori Y, Takato T, Diclofenac sodium induced Stevens–Johnson syndrome in a hospitalized patient during treatment of splenic injury and mandibular fracture, Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology, Available online 31 July 2013.

  8. Tremblayemail L, Pineton de Cham brun G, De Vroey B, Lavogiez C, Delaporte E, Colombel J, Cortot A. Stevens–Johnson syndrome with sulfasalazine treatment: Report of two cases. Journal of Crohn’s and Colitis Volume 5, Issue 5 , 2011, 457-460.

  9. Valeyrie-Allanore L, Ingen-Housz- Oro S, Chosidow O, Wolkenstein P, 308 REVISTA MEDICA DE COSTA RICA Y CENTROAMERICA French referral center management of Stevens–Johnson syndrome/toxic epidermal necrolysis, Dermatologica Sinica, Volume 31, Issue 4, 2013, 191-195.

  10. Weinand C, Xu W, Perbix W, Lefering R, Maegele M, Rathert M, Spilker G, 27 years of a single burn centre experience with Stevens–Johnson syndrome and toxic epidermal necrolysis: Analysis of mortality risk for causative agents, Burns, Volume 39, Issue 7, November 2013, 1449-1455.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Med Cos Cen. 2014;71